Expert Video - When should biomarker testing be done in NSCLC?
Cancer expert Dr. Robert Winn talks about the importance of discussing biomarker testing as soon as possible, even before getting a definitive diagnosis of non-small-cell lung cancer. Patients should also ask about removing additional tissue or repeating biomarker testing if samples are taken, in order to yield the most accurate results. Dr. Winn encourages patients to take advantage of precision medicine to receive lung cancer treatments tailored to their specific mutations.
Share with family and friends:
Click here to take our SURVEY Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.
This educational activity has been developed by
A Breath of Hope Lung Foundation and Mechanisms in Medicine Inc.
This activity is supported by educational grants from AstraZeneca Pharmaceuticals, Bristol-Myers Squibb Foundation Inc., Bristol-Myers Squibb Grants and Giving, Foundation Medicine, Genentech, Merck Sharp & Dohme LLC , Neogenomics, Novartis, and Pfizer.
This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.